Lawrence Greiten

Associate Professor

University of Arkansas for Medical Sciences

faculty

Surgery, College of Medicine

4 h-index 44 pubs 66 cited

Research Areas

Congenital Heart Disease Studies Cardiac Structural Anomalies and Repair Child and Adolescent Health Anesthesia and Pain Management Surgical Simulation and Training Decision-Making and Behavioral Economics Cardiovascular Function and Risk Factors

Links

UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Lawrence Greiten's research focuses on pediatric cardiothoracic surgery, with recent publications addressing the management of post-operative chylothorax in children with congenital heart disease (CHD), novel surgical approaches for aberrant right subclavian artery, and cognitive biases in decision-making within pediatric cardiology and cardiothoracic surgery. His work also examines left ventricular dysfunction following ventricular septal defect repair in infants, the effectiveness of the MITRIS RESILIA mitral valve in young patients, and outcomes of pulmonary valve replacement. Additionally, Greiten investigates developmental language trajectories in children with critical CHD and cardiac function decline after anesthesia and catheterization in pediatric cardiac transplant recipients.

Greiten has published 44 papers and has an h-index of 4. He collaborates extensively with colleagues at the University of Arkansas for Medical Sciences, including Brian Reemtsen (25 shared publications), Thomas Heye (11 shared publications), Markus S. Renno (9 shared publications), and Monroe McKay (5 shared publications). His recent activity indicates ongoing contributions to the field.

Research Overview

Pediatric Cardiothoracic Surgery

Metrics

h-index: 4
Publications: 44
Citations: 66

Selected Publications

Developmental language trajectories in children with critical CHD (2025) DOI
When High-Risk Ductal Stenting Goes Wrong: Use of Percutaneous VV ECMO Support and Acute Left Pulmonary Artery Loss (2025) DOI
Cardiac Function Decline After General Anesthesia and Cardiac Catheterization in Pediatric Cardiac Transplant Recipients (2024) DOI
Cognitive Biases in High-Stakes Decision-Making: Implications for Joint Pediatric Cardiology and Cardiothoracic Surgery Conference (2024) DOI
Author Response to Letter to the Editor Re: “Left Ventricular Dysfunction Following Repair of Ventricular Septal Defects in Infants” (2024) DOI
Left Ventricular Dysfunction Following Repair of Ventricular Septal Defects in Infants (2024) DOI
Left Ventricular Dysfunction Following Repair of Ventricular Septal Defects in Infants (2023) DOI
Aberrant right subclavian artery: a novel approach and an overview of operative techniques (2023) DOI
Arterial switch operation for complex d-transposition of the great arteries with aortopulmonary window (2023) DOI
The MITRIS RESILIA mitral valve is a safe and effective option for mitral valve replacement in young patients requiring mitral valve replacement (2022) DOI
Development of consensus recommendations for the management of post-operative chylothorax in paediatric CHD (2022) DOI
Imaging Technique and Index of Suspicion Matter: Rare Vascular Ring (2021) DOI
Congenital cervical rib causing thoracic outlet syndrome (2021) DOI
Pediatric Orthotopic Heart Transplant Requiring a Novel Cardiectomy with Anastomoses at the Atrioventricular Groove (2021) DOI

Research Interests

Throughout his training and early career, Dr. Greiten has demonstrated a dedicated and focused research path which enhances the quality of care he provides to his patients as a congenital pediatric cardiac surgeon. Furthermore, Dr. Greiten has quickly become an active and funded investigator at UAMS/Arkansas Children’s Hospital. Dr. Greiten’s clinical research interests include: clinical outcomes of palliative and definitive repairs of congenital cardiac malformations, neurodevelopmental outcomes after cardiac surgery, single ventricle pathophysiology, and cardiac transplantation. Dr. Greiten has also published several surgical education projects and has an interest in developing simulation platforms pertaining to extracorporeal membrane oxygenation, minimally invasive cardiac and endovascular techniques. Throughout his early career, Dr. Greiten’s research has been supported with nearly one million dollars in funding. Lastly, during his surgical training Dr. Greiten successfully completed a Master’s in Biomedical Sciences, Clinical and Translational Science where he published several papers on thromboprophylaxis and became an internationally renowned expert shifting the paradigm of novel anticoagulation strategies. In his career, Dr. Greiten has been the primary or major contributor of multiple publications, several book chapters, as well as various abstracts and surgical videos. In the process Dr. Greiten has received numerous research awards at various national conferences and institutions.